These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16634928)
21. Slitlamp biomicroscopy of the tear film of patients using topical Restasis and Refresh Endura. Solomon R; Perry HD; Donnenfeld ED; Greenman HE J Cataract Refract Surg; 2005 Apr; 31(4):661-3. PubMed ID: 15899439 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease. Hardten DR; Brown MJ; Pham-Vang S Curr Med Res Opin; 2007 Sep; 23(9):2083-91. PubMed ID: 17822610 [TBL] [Abstract][Full Text] [Related]
23. A preliminary study of changes in tear film proteins in the feline eye following nictitating membrane removal. Petznick A; Evans MD; Madigan MC; Garrett Q; Sweeney DF Vet Ophthalmol; 2012 May; 15(3):164-71. PubMed ID: 22050623 [TBL] [Abstract][Full Text] [Related]
24. Tear film concentrations of doxycycline following oral administration in ophthalmologically normal dogs. Collins SP; Labelle AL; Dirikolu L; Li Z; Mitchell MA; Hamor RE J Am Vet Med Assoc; 2016 Sep; 249(5):508-14. PubMed ID: 27556265 [TBL] [Abstract][Full Text] [Related]
25. Effect of lacrimal punctal occlusion on tear production and tear fluorescein dilution in normal dogs. Gelatt KN; MacKay EO; Widenhouse C; Widenhouse TS; Stopek JB Vet Ophthalmol; 2006; 9(1):23-7. PubMed ID: 16409241 [TBL] [Abstract][Full Text] [Related]
26. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome. Kim EC; Choi JS; Joo CK Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318 [TBL] [Abstract][Full Text] [Related]
27. Role of the tear film in the optical quality of the human eye. Montés-Micó R J Cataract Refract Surg; 2007 Sep; 33(9):1631-5. PubMed ID: 17720082 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Rao SN; Rao RD Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659 [TBL] [Abstract][Full Text] [Related]
29. Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys. Trattler W; Katsev D; Kerney D Clin Ther; 2006 Nov; 28(11):1848-56. PubMed ID: 17213005 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of topical cyclosporine for the treatment of ocular rosacea. Schechter BA; Katz RS; Friedman LS Adv Ther; 2009 Jun; 26(6):651-9. PubMed ID: 19551353 [TBL] [Abstract][Full Text] [Related]
31. Corneal sensitivity and aqueous tear production in dogs undergoing evisceration with intraocular prosthesis placement. Blocker T; Hoffman A; Schaeffer DJ; Wallin JA Vet Ophthalmol; 2007; 10(3):147-54. PubMed ID: 17445075 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of an ear rinse containing tromethamine, EDTA, benzyl alcohol and 0.1% ketoconazole on Malassezia organisms from dogs with otitis externa. Cole LK; Luu DH; Rajala-Schultz PJ; Meadows C; Torres AH Vet Dermatol; 2007 Apr; 18(2):115-9. PubMed ID: 17355426 [TBL] [Abstract][Full Text] [Related]
33. Effect of artificial tears on tear stress test. Khanal S; Simmons PA; Pearce EI; Day M; Tomlinson A Optom Vis Sci; 2008 Aug; 85(8):732-9. PubMed ID: 18677237 [TBL] [Abstract][Full Text] [Related]
34. Ocular bioerodible minitablets as strategy for the management of microbial keratitis. Weyenberg W; Vermeire A; Dhondt MM; Adriaens E; Kestelyn P; Remon JP; Ludwig A Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3229-33. PubMed ID: 15326145 [TBL] [Abstract][Full Text] [Related]
35. Constant rate infusion for topical ocular delivery in horses: a pilot study. Myrna KE; Herring IP Vet Ophthalmol; 2006; 9(1):1-5. PubMed ID: 16409238 [TBL] [Abstract][Full Text] [Related]
36. Investigation of corneal effect of different types of artificial tears in a simulated dry eye condition using a novel porcine dry eye model (pDEM). Choy EP; Cho P; Benzie IF; Choy CK Cornea; 2006 Dec; 25(10):1200-4. PubMed ID: 17172898 [TBL] [Abstract][Full Text] [Related]
37. Management of dry eye disease. Lemp MA Am J Manag Care; 2008 Apr; 14(3 Suppl):S88-101. PubMed ID: 18452372 [TBL] [Abstract][Full Text] [Related]
38. Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model. Riazi-Esfahani M; Peyman GA; Aydin E; Kazi AA; Kivilcim M; Sanders DR Cornea; 2006 Aug; 25(7):801-5. PubMed ID: 17068457 [TBL] [Abstract][Full Text] [Related]
39. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice. Villareal AL; Farley W; Pflugfelder SC Eye Contact Lens; 2006 Dec; 32(6):272-6. PubMed ID: 17099387 [TBL] [Abstract][Full Text] [Related]
40. Microorganisms isolated from the corneal surface before and during topical cyclosporine treatment in dogs with keratoconjunctivitis sicca. Salisbury MA; Kaswan RL; Brown J Am J Vet Res; 1995 Jul; 56(7):880-4. PubMed ID: 7574155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]